PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
40.10%
Net income growth under 50% of MRVL's 188.14%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
5.62%
Some D&A expansion while MRVL is negative at -1.65%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-57.14%
Negative yoy deferred tax while MRVL stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
199.59%
Well above MRVL's 8.81% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
87.63%
Some inventory rise while MRVL is negative at -19.91%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
No Data
No Data available this quarter, please select a different quarter.
272.97%
Growth well above MRVL's 14.62%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-841.00%
Negative yoy while MRVL is 0.00%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-43.00%
Negative yoy CFO while MRVL is 46.83%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
8.77%
Some CapEx rise while MRVL is negative at -63.40%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
7.91%
Purchases growth of 7.91% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-27.75%
We reduce yoy sales while MRVL is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-129.65%
We reduce yoy invests while MRVL stands at 90.46%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-46.67%
Both yoy lines negative, with MRVL at -100.11%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
-0.66%
We cut yoy buybacks while MRVL is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.